| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | NEOPHOTONICS CORP | 300,000 | 2,859,000 | 6.28% | ||
| 2 | AMGEN INC | 40,000 | 6,086,000 | 13.38% | ||
| 3 | Theravance Biopharma Inc | 325,000 | 7,374,000 | 16.21% | ||
| 4 | HCA HOLDINGS INC | 100,000 | 7,701,000 | 16.92% | ||
| 5 | ALPHABET INC | 15,000 | 10,382,000 | 22.82% | ||
| 6 | NEXPOINT RESIDENTIAL TR INC | 609,905 | 11,100,000 | 24.39% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-076357, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
